AETERNA ZENTARIS INC (AEZS.CA) Stock Price, Quote, News and Overview
TSX:AEZS - Toronto Stock Exchange - CA0079756007 - Common Stock - Currency: CAD
AEZS.CA Quote, Performance and Key Statistics
TSX:AEZS (11/22/2024, 7:00:00 PM)
4.12
+0.06 (+1.48%)
The current stock price of AEZS.CA is 4.12 CAD. In the past month the price decreased by -18.25%. In the past year, price decreased by -66.34%.
AEZS.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 313.76M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 311.54M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 260.35M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 205.53M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 119.02M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 113.30M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 90.48M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 90.05M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 19.38 | 69.10M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 58.20M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 51.14M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 24.5 | 34.36M |
Related stock screener links
About AEZS.CA
Company Profile
COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
Company Info
AETERNA ZENTARIS INC
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53
TORONTO ONTARIO 29486 CA
CEO: Klaus Paulini
Employees: 12
Phone: 18439003201
AETERNA ZENTARIS INC / AEZS.CA FAQ
What is the stock price of AETERNA ZENTARIS INC today?
The current stock price of AEZS.CA is 4.12 CAD. The price increased by 1.48% in the last trading session.
What is the ticker symbol for AETERNA ZENTARIS INC stock?
The exchange symbol of AETERNA ZENTARIS INC is AEZS and it is listed on the Toronto Stock Exchange exchange.
On which exchange is AEZS.CA stock listed?
AEZS.CA stock is listed on the Toronto Stock Exchange exchange.
What is AETERNA ZENTARIS INC worth?
AETERNA ZENTARIS INC (AEZS.CA) has a market capitalization of 15.49M CAD. This makes AEZS.CA a Nano Cap stock.
How many employees does AETERNA ZENTARIS INC have?
AETERNA ZENTARIS INC (AEZS.CA) currently has 12 employees.
What are the support and resistance levels for AETERNA ZENTARIS INC (AEZS.CA) stock?
AETERNA ZENTARIS INC (AEZS.CA) has a resistance level at 4.13. Check the full technical report for a detailed analysis of AEZS.CA support and resistance levels.
Is AETERNA ZENTARIS INC (AEZS.CA) expected to grow?
The Revenue of AETERNA ZENTARIS INC (AEZS.CA) is expected to decline by -2.27% in the next year. Check the estimates tab for more information on the AEZS.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AETERNA ZENTARIS INC (AEZS.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AEZS.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AEZS.CA, evaluating the profitability, health, valuation and growth aspects
- AETERNA ZENTARIS INC (AEZS.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AETERNA ZENTARIS INC (AEZS.CA) Sales and EPS estimates to see what analysts future expectations are.
- AETERNA ZENTARIS INC (AEZS.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AETERNA ZENTARIS INC (AEZS.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AETERNA ZENTARIS INC (AEZS.CA) Stock Chart to make your own analysis
- AETERNA ZENTARIS INC (AEZS.CA) Latest news and press-releases to stay up to date.
Does AETERNA ZENTARIS INC (AEZS.CA) stock pay dividends?
AEZS.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of AETERNA ZENTARIS INC (AEZS.CA)?
AETERNA ZENTARIS INC (AEZS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.41).
AEZS.CA Technical Analysis
AEZS.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AEZS.CA. AEZS.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AEZS.CA Financial Highlights
Over the last trailing twelve months AEZS.CA reported a non-GAAP Earnings per Share(EPS) of -15.41. The EPS decreased by -274.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -56.8% | ||
| ROE | -139.22% | ||
| Debt/Equity | 0.01 |
AEZS.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to AEZS.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 68.75% and a revenue growth -2.27% for AEZS.CA